In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Abbott licenses rights to 24 drugs from Zydus Cadila

Executive Summary

Indian pharmaco Zydus Cadila has granted Abbott Laboratories Inc. rights to commercialize 24 branded generics in 15 emerging markets (Czech Republic, Egypt, Hungary, Poland, Romania, Russia, Turkey, Brazil, Indonesia, Mexico, Philippines, South Africa, Thailand, Vietnam, and Ukraine). Abbott also gets the option to license 40 other products.
Deal Industry
  • Pharmaceuticals
  • Pharmaceuticals
    • Generic Drugs
Deal Status
  • Final
Deal Type
  • Alliance
    • Marketing (Licensing)

Related Companies